These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6569872)

  • 1. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
    Varaldo PE; Debbia E; Schito GC
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():35-41. PubMed ID: 6569872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):615-8. PubMed ID: 3847272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
    Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
    J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.
    Varaldo PE; Cipriani P; Focá A; Geraci C; Giordano A; Madeddu MA; Orsi A; Pompei R; Prenna M; Repetto A
    J Clin Microbiol; 1984 Jun; 19(6):838-43. PubMed ID: 6565709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
    Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
    Eng RH; Smith SM; Buccini FJ; Cherubin CE
    J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of rifampicin against staphylococci, with special reference to multiresistant strains.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():7-16. PubMed ID: 6236192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis.
    Hansen BG
    Acta Pathol Microbiol Immunol Scand B; 1983 Aug; 91(4):279-84. PubMed ID: 6556002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
    Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
    J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Watanakunakorn C
    Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.
    Arditi M; Yogev R
    Antimicrob Agents Chemother; 1989 Feb; 33(2):245-7. PubMed ID: 2719468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.